Artificial Intelligence (AI) platforms Could Enhance Jaguar Health’s development and anticipated commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
April 14, 2026
Host Jonathan Miller interviews CEO: David Danielsen. He shares how CairnSurgical, Inc. is specializing in the development and manufacturing of advanced surgical instruments and devices.